Untargeted Proteomics and Systems-Based Mechanistic Investigation of Artesunate in Human Bronchial Epithelial Cells
- 21 September 2015
- journal article
- research article
- Published by American Chemical Society (ACS) in Chemical Research in Toxicology
- Vol. 28 (10) , 1903-1913
Abstract
The antimalarial drug artesunate is a semisynthetic derivative of artemisinin, the principal active component of a medicinal plant Artemisia annua. It is hypothesized to attenuate allergic asthma via inhibition of multiple signaling pathways. We used a comprehensive approach to elucidate the mechanism of action of artesunate by designing a novel biotinylated dihydroartemisinin (BDHA) to identify cellular protein targets of this anti-inflammatory drug. By adopting an untargeted proteomics approach, we demonstrated that artesunate may exert its protective anti-inflammatory effects via direct interaction with multiple proteins, most importantly with a number of mitochondrial enzymes related to glucose and energy metabolism, along with mRNA and gene expression, ribosomal regulation, stress responses, and structural proteins. In addition, the modulatory effects of artesunate on various cellular transcription factors were investigated using a transcription factor array, which revealed that artesunate can simultaneously modulate multiple nuclear transcription factors related to several major pro- and anti-inflammatory signaling cascades in human bronchial epithelial cells. Artesunate significantly enhanced nuclear levels of nuclear factor erythroid-2-related factor 2 (Nrf2), a key promoter of antioxidant mechanisms, which is inhibited by the Kelch-like ECH-associated protein 1 (Keap1). Our results demonstrate that, like other electrophilic Nrf2 regulators, artesunate activates this system via direct molecular interaction/modification of Keap1, freeing Nrf2 for transcriptional activity. Altogether, the molecular interactions and modulation of nuclear transcription factors provide invaluable insights into the broad pharmacological actions of artesunate in inflammatory lung diseases and related inflammatory disorders.Keywords
Funding Information
- National Institute of Environmental Health Sciences (P30-ES002109)
- Centre for Environmental and Occupational Health Research, National University of Singapore
This publication has 51 references indexed in Scilit:
- How Metabolism Generates Signals during Innate Immunity and InflammationJournal of Biological Chemistry, 2013
- Anti‐allergic action of anti‐malarial drug artesunate in experimental mast cell‐mediated anaphylactic modelsAllergy, 2012
- Anti-Malarial Drug Artesunate Attenuates Experimental Allergic Asthma via Inhibition of the Phosphoinositide 3-Kinase/Akt PathwayPLOS ONE, 2011
- The Molecular Mechanism of Action of Artemisinin—The Debate ContinuesMolecules, 2010
- Artemisinin Directly Targets Malarial Mitochondria through Its Specific Mitochondrial ActivationPLOS ONE, 2010
- ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networksBioinformatics, 2009
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNature Protocols, 2008
- Metabolic reconfiguration is a regulated response to oxidative stressJournal of Biology, 2008
- Role of Early Growth Response-1 (Egr-1) in Interleukin-13-induced Inflammation and RemodelingJournal of Biological Chemistry, 2006
- Airway remodeling in asthma: New insightsJournal of Allergy and Clinical Immunology, 2003